BioSpace News Archive

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Beta Pharma, a biotech company focusing on innovative drug discovery and development in oncology, announce a strategic partnership.

Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the appointment of Pamela Stephenson, MPH, as Chief Commercial Officer, effective March 25, 2019.

IMV Inc., a clinical stage immuno-oncology corporation, released its financial and operational results for year ending December 31, 2018.

The healthcare technology company uses hashgraph to speed up healthcare credentialing from months to seconds with Ready Doc™

BD, a leading global medical technology company, issued the following statement related to the recent letter from FDA to health care providers regarding paclitaxel-coated devices:

The American Diabetes Association strongly supports the re-introduction of legislation to expand access to Diabetes Self-Management Training for Medicare beneficiaries.

Leading hearing protection company kicks off 2019 with strong review by trusted voices at Tiny Desk.

The drug sorafenib (Nexavar®) typically used for kidney and liver cancer treatment provided complete remission for breast cancer patient after lab discoveries

BioArctic AB announced that its partner Eisai has initiated the global Phase 3 confirmatory study of BAN2401 in patients with early Alzheimer´s disease.

Tiziana Life Sciences plc (the “Company”, “Tiziana Life Sciences” or “Tiziana”) (NASDAQ: TLSA; AIM: TILS), a US and UK biotechnology company that focuses on the discovery and development of novel molecules to treat human diseases in oncology and immunology, today announced that it has submitted*an Investigational New Drug application (“IND”) to the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial of enteric-coated capsules of Foralumab in healthy volunteers